single arm:Camrelizumab

2 trials

Sponsors

Anqing Municipal Hospital, The First Affiliated Hospital of Zhengzhou University

Conditions

Extrahepatic cholangiocarcinomaOvarian cancer

Phase 4

Single-arm, multicenter, prospective phase II clinical study of Camrelizumab in the treatment of advanced second-line and above ovarian cance

RecruitingChiCTR2000041447

Anqing Municipal HospitalOvarian cancer

Start: 2021-01-02Updated: 2021-03-15

Unknown Phase

Camrelizumab combined with hepatic arterial infusion chemotherapy for the treatment of advanced extrahepatic cholangiocarcinoma before surgery: a single-arm, prospective, open clinical study

RecruitingChiCTR2100044629

The First Affiliated Hospital of Zhengzhou UniversityExtrahepatic cholangiocarcinoma

Start: 2021-04-01Updated: 2022-04-25